Pancreatic cancer, a formidable and often overlooked adversary, has been steadily climbing the ranks of mortality in Australia, now second only to lung cancer in its annual death toll. This insidious disease, with its poor survival rates and elusive early detection, demands our urgent attention and a reevaluation of our national health priorities. The story of Katie Allen, a former Liberal MP and pediatrician, serves as a poignant reminder of the impact of this disease. Her daughter's observation of her jaundiced eyes led to a diagnosis that, unfortunately, proved fatal just two years later. This tragedy underscores the critical need for increased awareness and proactive measures to combat pancreatic cancer.
The statistics are alarming. According to the Australian Bureau of Statistics, deaths from pancreatic cancer have nearly doubled in the past two decades, growing at a rate 2.6 times that of overall cancer-related deaths. In 2024, it officially surpassed prostate cancer in its mortality count, with lung cancer being the only cancer type causing more cancer-related deaths. This alarming trend necessitates an urgent response, as the growth rate of pancreatic cancer deaths has accelerated by 40% in the past decade, compared to 27% in the previous decade. The five-year relative survival rate for pancreatic cancer remains unacceptably low at 14%, highlighting the dire need for improved detection and treatment.
The Pancare Foundation, led by Dr. Mark Buzza and Nurse Melanie Regan, advocates for the recognition of pancreatic cancer as a national health priority. They emphasize the absence of a national population screening program, similar to those for breast and bowel cancers, as a significant gap in our healthcare system. In the absence of such screening, they call for long-term investment in research to develop early detection technologies and surveillance systems for high-risk populations. This investment is crucial to improving the quality of life for patients and families, as pancreatic cancer's poor survival rates and arduous treatments result in significantly lower quality of life compared to other cancer types.
The National Pancreatic Cancer Roadmap, developed by Cancer Australia, provides a comprehensive framework for collective action across 33 priority domains. This roadmap aims to improve outcomes and survival for Australians diagnosed with pancreatic cancer. To support its implementation, Cancer Australia has partnered with leading universities to develop practical, evidence-based resources for health professionals and patients. The University of Queensland has taken the lead in developing clinical guidance and educational tools focused on early detection and diagnosis, aiming to reduce diagnostic delay and improve patient outcomes.
The University of Melbourne, in collaboration with HammondCare, the University of Queensland, and the University of Adelaide, has developed resources to improve access to pain management and early integration of palliative care. These resources include standardized referral pathways, pain assessment tools, and culturally appropriate guidance for Aboriginal and Torres Strait Islander peoples. Given the high symptom burden and limited survival associated with pancreatic cancer, effective pain and symptom management are essential components of high-quality supportive care.
However, the challenges of pancreatic cancer extend beyond early detection and treatment. The absence of a population-level screening program places a significant responsibility on healthcare professionals to recognize symptoms early and facilitate timely referrals. Yet, early recognition alone is insufficient. Systemic change is required, including investment in research to develop early detection technologies, surveillance of high-risk populations, personalized treatment approaches, supportive and palliative care, and public awareness and education.
In conclusion, the battle against pancreatic cancer requires a sustained, coordinated, and well-funded national response. By committing to earlier detection, personalized treatment approaches, and comprehensive supportive and palliative care, Australia can begin to change the trajectory of this disease and offer hope to the thousands of families affected each year. It is time to make pancreatic cancer a national health priority, supported by long-term investment in research, clinical innovation, workforce capability, and equitable access to care. Only then can we hope to make a meaningful difference in the lives of those affected by this insidious disease.
